These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

154 related items for PubMed ID: 2121409

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Disposition of fleroxacin, a new trifluoroquinolone, and its metabolites. Pharmacokinetics in renal failure and influence of haemodialysis.
    Singlas E, Leroy A, Sultan E, Godin M, Moulin B, Taburet AM, Dhib M, Fillastre JP.
    Clin Pharmacokinet; 1990 Jul; 19(1):67-79. PubMed ID: 2116256
    [Abstract] [Full Text] [Related]

  • 3. Disposition of fleroxacin, a new trifluoroquinolone, and its metabolites. Pharmacokinetics in elderly patients.
    Taburet AM, Devillers A, Thomare P, Fillastre JP, Veyssier P, Singlas E.
    Clin Pharmacokinet; 1990 Jul; 19(1):80-8. PubMed ID: 2116257
    [Abstract] [Full Text] [Related]

  • 4. Single and multiple dose pharmacokinetics of fleroxacin.
    Weidekamm E, Portmann R, Partos C, Dell D.
    J Antimicrob Chemother; 1988 Oct; 22 Suppl D():145-54. PubMed ID: 3144533
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Pharmacokinetics and body fluid penetration of fleroxacin in healthy volunteers.
    Sorgel F, Metz R, Naber K, Seelmann R, Muth P.
    J Antimicrob Chemother; 1988 Oct; 22 Suppl D():155-67. PubMed ID: 3144534
    [Abstract] [Full Text] [Related]

  • 8. A comparison of the penetration of two quinolones into intra-abdominal abscess.
    Tudor RG, Youngs DJ, Yoshioka K, Burdon DW, Keighley MR.
    Arch Surg; 1988 Dec; 123(12):1487-90. PubMed ID: 3142444
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Pharmacokinetics and metabolism of intravenous and oral fleroxacin in subjects with normal and impaired renal function and in patients on continuous ambulatory peritoneal dialysis.
    Stuck AE, Frey FJ, Heizmann P, Brandt R, Weidekamm E.
    Antimicrob Agents Chemother; 1989 Mar; 33(3):373-81. PubMed ID: 2499248
    [Abstract] [Full Text] [Related]

  • 13. 1H and 19F NMR relaxation studies of fleroxacin with Micrococcus luteus.
    Waibel B, Holzgrabe U.
    J Pharm Biomed Anal; 2007 Apr 11; 43(5):1595-601. PubMed ID: 17254731
    [Abstract] [Full Text] [Related]

  • 14. Single-dose pharmacokinetic study of ciprofloxacin and fleroxacin in healthy adult Nigerian volunteers.
    Chukwuani CM, Coker HA, Oduola AM, Ifudu ND, Sowunmi A.
    Chemotherapy; 1998 Apr 11; 44(6):369-76. PubMed ID: 9755295
    [Abstract] [Full Text] [Related]

  • 15. Pharmacokinetics of Ro 23-6240 (AM 833), a new trifluorinated quinolone.
    Weidekamm E, Stöckel K, Dell D.
    Chemioterapia; 1987 Jun 11; 6(2 Suppl):307-8. PubMed ID: 3151346
    [No Abstract] [Full Text] [Related]

  • 16. In-vitro activity of fleroxacin against isolates causing complicated urinary tract infections and concentrations in seminal and prostatic fluid and in prostatic adenoma tissue.
    Naber KG, Sörgel F, Kees F, Schumacher H, Metz R, Grobecker H.
    J Antimicrob Chemother; 1988 Oct 11; 22 Suppl D():199-207. PubMed ID: 2462556
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.